Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Publication Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Danielle Pillsbury2017年5月1日
CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Publication CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Danielle Pillsbury2017年3月1日
Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer Publication Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer Danielle Pillsbury2016年12月18日
Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models Publication Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models Danielle Pillsbury2016年10月5日
Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains Publication Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains Danielle Pillsbury2016年10月1日
Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation Publication Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation Danielle Pillsbury2016年8月1日
Physiologically-based Pharmacokinetic Modeling in Pediatric Oncology Drug Development Publication Physiologically-based Pharmacokinetic Modeling in Pediatric Oncology Drug Development Danielle Pillsbury2016年7月1日
Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs Publication 得られた教訓 : Dose Selection of Small Molecule-targeted Oncology Drugs Danielle Pillsbury2016年6月1日
Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Kinetics in Medullary Thyroid Cancer Patients Receiving Cabozantinib Publication Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Kinetics in Medullary Thyroid Cancer Patients Receiving Cabozantinib Nonlinear mixed effects models were developed to describe the relationship between cabozantinib exposure and target…Danielle Pillsbury2016年4月27日
Breast Cancer Resistance Protein Abundance, but Not mRNA Expression, Correlates with Estron e-3-Sulfate Transport in Caco-2 Publication Breast Cancer Resistance Protein Abundance, but Not mRNA Expression, Correlates with Estron e-3-Sulfate Transport in Caco-2 Transporter mRNA and protein expression data are used to extrapolate in vitro transporter kinetics to in…Danielle Pillsbury2016年4月1日